Lensar (LNSR) Preferred Stock Liabilities (2019)
Lensar (LNSR) reported Preferred Stock Liabilities of $36.4 million for Q4 2019.
Lensar (LNSR) Preferred Stock Liabilities (2019) Analysis & Trends
Lensar (LNSR) has 1 years of Preferred Stock Liabilities data on file, last reported at $36.4 million in Q4 2019.
- Preferred Stock Liabilities for Q4 2019 came in at $36.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $36.4 million (changed N/A YoY), and the FY2019 annual result was $36.4 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $36.4 million in Q4 2019 per LNSR's latest filing.
- Over five years, Preferred Stock Liabilities peaked at $36.4 million in Q4 2019 and troughed at $36.4 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 36.42 Mn |